%0 Journal Article
%T Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
%A Jochen H Lorch
%J Cancer Management and Research
%D 2009
%I 
%R http://dx.doi.org/10.2147/CMAR.S5134
%X le of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer Review (4356) Total Article Views Authors: Jochen H Lorch Published Date November 2009 Volume 2009:1 Pages 151 - 154 DOI: http://dx.doi.org/10.2147/CMAR.S5134 Jochen H Lorch Dana Farber Cancer institute, Boston, MA, USA Abstract: Squamous cell cancer of the head and neck (SCCHN) is a major contributor to morbidity and mortality worldwide. In recent years, inhibition of the epidermal growth factor receptor has become an established treatment strategy in SCCHN both in the up-front treatment and in the recurrent and metastatic setting. This review summarizes the most important developments of the recent past and provides an overview of newer developments.
%K squamous cell cancer
%K head
%K neck
%K epidermal growth factor receptor
%U https://www.dovepress.com/role-of-egf-inhibitors-in-the-treatment-of-recurrent-or-metastatic-squ-peer-reviewed-article-CMAR